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tory mechanisms may play roles in the aetiology of hip OA via an
effect on cartilage.
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Purpose: An inﬂammation of the medial perimeniscal synovium is
common in OA, as synovial inﬂammation in OA occurs locally in
areas of cartilage loss. The synovial inﬂammation in early stage
of knee OA is enhanced in comparison to that of late stage of
OA. These suggest that the expression proﬁles of inﬂammatory
proteins in synovium are different depending upon the condition
of the knee joint such as the amount of a remaining articular
cartilage and osteophyte formation. This study hypothesized that
the expression patterns of the inﬂammatory mediators in the
medial compartment of the patients with end-stage of knee OA
(KL 4) that lack articular cartilage and show an eburnation of the
medial contact surface is different from those with progressive
stage (KL 2 and 3) of knee OA in which the articular cartilage
remains, while the varus deformation and other clinical features
of the former is exaggerated in comparison to that of the later.
Therefore, the expression levels of inﬂammation mediators in the
synovium of patients with the both end-stage and progressive
stage of knee OA were examined to conﬁrm the hypothesis.
Methods: Twenty-three patients who had knee OA (KL2 or higher)
and underwent joint replacement (n=19) or arthroscopic surgery
(n=4) in the hospital were recruited for this study. Synovial tissue
samples of the 10 patients who underwent ACL reconstruction
were also obtained as a control. The following primary antibod-
ies were used in immunohistochemical analysis: CD31, NF-κB,
MMP-1, COX-2, IL-1β, TGF-β. A semi-quantitative analysis of the
stained sections was conducted using the method as described
previously. Clinical manifestation was evaluated by the Japanese
Knee Osteoarthritis Measure (JKOM). JKOM is higher in patients
with more pain and physical disabilities.
Results: Immunohistochemical analyses have revealed the MMP-
1, COX-2 and IL-1β expression in the synovium of end-stage OA
were signiﬁcantly reduced in comparison to those of progressive
OA. On the other hand, the expression of TGF-β in the synovium
of end-stage OA was signiﬁcantly increased in comparison to that
of progressive OA. The MMP-1, IL-1β and TGF-β expression in
the synovium were signiﬁcantly correlated with the radiographic
and clinical manifestations of knee OA.
Conclusions: The expression of MMP-1, COX2 and IL-1β in syn-
ovial tissues is thought to be activated by degenerated articular
cartilage. Therefore, the expression of these mediators of inﬂam-
mation was enhanced in synovial tissues in the progressive OA
in comparison to that in end-stage OA. The relationship between
the expression levels of the mediators for inﬂammation and the
radiographic and outcome measures for OA conﬁrmed the accu-
racy of the immunohistochemical analysis. TGF-β is thought to be
involved in osteophyte formation and ﬁbrosis of the joint capsule
in OA. The formation of an osteophyte is considered to be one of
the signs of severe OA. Therefore, the result of TGF-β expression
of the synovium in the patients with end-stage of knee OA in
comparison to that with the progressive OA may reﬂect the sever-
ity of OA in this group in comparison to that in the progressive
OA. These data indicated that the expression proﬁles of syniovial
tissue inﬂammation in end-stage OA were distinct from those in
progressive OA, reﬂecting the condition of the joint in patients with
OA, such as the volume of the remaining articular cartilage and
the degree of osteophyte formation.
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Purpose: Evaluation of knock-out (KO) mice in osteoarthritis (OA)
models provides an excellent tool to validate OA targets in vivo.
Interleukin-1β (IL-1β) is recognized as a critical cytokine, and is
frequently utilized to induce a number of destructive enzymes and
signaling molecules, implicated in the pathophysiology of OA. This
study sought to elucidate the role of IL-1β, and its downstream
signaling pathway, by utilizing KO mice in a surgical instability in
vivo model, as well as in vitro explant and cell line studies.
Methods: All animal studies were performed with IACUC ap-
provals. All KO mice were purchased commercially, bred from ho-
mozygous parents and the recommended wild-type (WT) controls
were utilized. The IL-1β KO mice were purchased from Taconic
(Germantown, NY), and the Interleukin-1 Receptor I (IL1RI), and
Interleukin-1 Receptor Accessory Protein (IL1RaP) KO and con-
trol WT mice were from Jackson Laboraties (Bar Harbor, ME).
Male mice (10 per group) underwent surgical destabilization of
the medial meniscus (DMM) when 10 weeks of age, and were
group housed until sacriﬁced 8-weeks later. Following euthanasia,
right knees were collected for histopathology. Hip cartilage was
harvested from 3-week-old IL1R1 and IL1RaP KO and WT mice
for explant studies as well as for generation of cell lines. Explants
were treated with media alone or IL-1. Cell lines were stimulated
with media +/- 10 ng/ml IL-1β for 24 hours and RNA isolated for
qRT-PCR of MMP-13, SOX9, ADAMTS4 and NOS2.
Results: The IL-1β KO had signiﬁcantly less OA than the WT in 2
separate studies. No differences to WT were observed for IL1R1
(performed twice), or IL1RaP KOs. Both IL1R1 and IL1RaP KO
explants were protected from IL-1 induced proteoglycan release.
The IL1R1 and IL1RaP WT cell lines had increases in MMP-13,
ADAMTS4 and NOS2, and decreases in SOX9, following IL-1
treatment. The IL1R1 and IL1RaP KO cell lines both had a lack
of induction of MMP-13 following IL IL-1 treatment, yet SOX-
9 repression and ADAMTS-4 induction remained similar to WT.
The IL1R1 KO cell line had no induction of NOS2, following IL-
1 stimulation, while the IL1RaP KO continued to have dramatic
up-regulation.
Conclusions: The IL-1β KO was protected in the DMM model,
supporting the importance of this cytokine in OA. However, dele-
tion of downstream signaling molecules, IL1R1 or IL1RaP had no
effect in the DMM model. Explant studies conﬁrmed that IL1R1
or IL1RaP KOs did not respond to IL-1 treatment with release
of proteoglycan. The cell lines studies found MMP-13 was sup-
pressed, but unexpectedly ADAMTS-4 was still induced and SOX9
repressed in both KO cell lines, suggesting that IL-1β can act be-
yond the canonical signaling pathway in cartilage, in accordance
with published studies in brain. These ﬁndings indicate that the
role of IL-1β signaling in cartilage is more complicated than previ-
ously recognized and that studies utilizing KO mice and cell lines
may be of great utility to explore the alternate mechanisms.
